McKenzie A Dirr,Areeba Ahmed,Daniel I Schlessinger et al.
McKenzie A Dirr et al.
Importance: Currently, there are no standardized outcome domains or measures in clinical trials for facial aging. Heterogeneity in outcome domains and measurement instruments across clinical trials creates difficulty in d...
Chelsea Deitelzweig,Ravi Dhawan,Kyle King et al.
Chelsea Deitelzweig et al.
Systemic Proteomic Alterations and Predictive Biomarkers of Paroxetine Response in Refractory Rosacea: A Secondary Analysis of a Randomized Clinical Trial [0.03%]
氟西汀治疗难治性酒渣鼻的系统蛋白组学改变及预测生物标志物：随机对照试验的二次分析
Ben Wang,Xinyi Deng,Yifan Zhang et al.
Ben Wang et al.
Importance: Rosacea is a chronic inflammatory cutaneous disorder characterized by persistent erythema and vascular dysregulation. While paroxetine has shown clinical efficacy in reducing these symptoms, the systemic molec...
Clinicopathologic Features and Long-Term Outcomes of Adult Hypopigmented Mycosis Fungoides [0.03%]
成人无色素性蕈样肉芽肿的临床病理特征及长期预后
Jong Bin Park,Shamir Geller,Viviane Liao et al.
Jong Bin Park et al.
Importance: Hypopigmented mycosis fungoides (HMF) is uncommon in adults, and data on clinicopathologic features and long-term outcomes remain sparse. Obje...
The Economics of Nicotinamide for Keratinocyte Carcinoma Prevention: What Does the Evidence (Not) Support? [0.03%]
烟酰胺预防角质细胞癌的经济学：证据（不）支持什么？
Ivo Abraham,Adewole S Adamson,Howa Yeung
Ivo Abraham
Joachim Hübner,Laura Schumann,Nora Eisemann et al.
Joachim Hübner et al.
Importance: In Germany, a population-based skin cancer screening (SCS) program was implemented in 2008. The benefit of the intervention is unclear. Object...
Madeline Sage,Christopher J Sayed
Madeline Sage
Cost-Effectiveness of Oral Nicotinamide for Keratinocyte Carcinoma Prevention [0.03%]
口服烟酰胺预防角质细胞癌的成本效益分析
David Perez,Kimberly F Breglio,Katlyn M Knox et al.
David Perez et al.
Importance: Keratinocyte carcinoma (KC) is the most common cancer in the US, resulting in considerable clinical and economic burdens. Nicotinamide has been shown to reduce new KCs among high-risk patients. Despite growing...
Yihang Xie,Xin Zeng,Xuefeng Zhang
Yihang Xie
Ecthymalike Ulcerations in Patients With Lung Cancer Treated With Combined Amivantamab and Osimertinib [0.03%]
氨磺必利和奥希替尼联合治疗肺癌患者的类蜂窝织炎性溃疡
Stephen Li,Yoo Jung Kim,Esther Choi et al.
Stephen Li et al.